|
ZNF205 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.68340000003842E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.3970999999976E-06 |
| Normal-vs-Stage2 |
7.72410000000612E-05 |
| Normal-vs-Stage3 |
3.64430000000526E-05 |
| Normal-vs-Stage4 |
3.557900E-04 |
| Stage1-vs-Stage2 |
3.605200E-01 |
| Stage1-vs-Stage3 |
6.946000E-01 |
| Stage1-vs-Stage4 |
3.523400E-01 |
| Stage2-vs-Stage3 |
5.754600E-01 |
| Stage2-vs-Stage4 |
9.051600E-01 |
| Stage3-vs-Stage4 |
5.019600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.54360000004239E-06 |
| Normal-vs-AfricanAmerican |
5.535100E-03 |
| Normal-vs-Asian |
1.944119999997E-05 |
| Caucasian-vs-AfricanAmerican |
4.352600E-01 |
| Caucasian-vs-Asian |
8.416200E-02 |
| AfricanAmerican-vs-Asian |
6.933600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.35760000411034E-08 |
| Normal-vs-Female |
1.86147999999831E-05 |
| Male-vs-Female |
7.719600E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.7343000000023E-05 |
| Normal-vs-Age(41-60Yrs) |
2.71159999998272E-06 |
| Normal-vs-Age(61-80Yrs) |
5.91249999999377E-05 |
| Normal-vs-Age(81-100Yrs) |
2.567000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.154400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.796600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.604400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.184800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.936000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.820400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.715700E-03 |
| Classical-VS-Follicular |
7.830200E-01 |
| Classical-VS-Other |
1.038960E-01 |
| Classical-VS-Normal |
5.43710000022735E-07 |
| Tall-VS-Follicular |
1.206260E-02 |
| Tall-VS-Other |
3.582200E-02 |
| Tall-VS-Normal |
8.658500E-02 |
| Follicular-VS-Other |
1.025390E-01 |
| Follicular-VS-Normal |
2.4046999999916E-05 |
| Other-VS-Normal |
1.248530E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.00680000003628E-07 |
| Normal-vs-N1 |
9.58279999999645E-05 |
| N0-vs-N1 |
5.147800E-01 |
|
|
